Journal articleCancer Res2024
IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer.
- Journal
- Cancer Res
- Published
- 1 September 2024
- Citations
- 26
- Type
- Article
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 1
Grants 6
- Cognitive Impairment, Multimorbidity, and end-of-life care in older cancer patients P30CA043703↗
- Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer R01CA212600↗
- Optimizing anti-wild-type IDH1 therapy in pancreatic cancer R01CA287672↗
- Developing a patient derived model platform to treat BRCA1/2-mutant pancreatic cancers R21CA263996↗
- Targeting pancreatic cancer's metabolic addiction to HuR R37CA227865↗
- Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens U01CA224012↗